25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Silo Pharma Inc
Buy, Hold or Sell?

Let's analyze Silo Pharma Inc together

I guess you are interested in Silo Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Silo Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Silo Pharma Inc

I send you an email if I find something interesting about Silo Pharma Inc.

1. Quick Overview

1.1. Quick analysis of Silo Pharma Inc (30 sec.)










1.2. What can you expect buying and holding a share of Silo Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
8.1%

What is your share worth?

Current worth
$1.51
Expected worth in 1 year
$1.35
How sure are you?
32.4%

+ What do you gain per year?

Total Gains per Share
$-0.16
Return On Investment
-13.1%

For what price can you sell your share?

Current Price per Share
$1.22
Expected price per share
$1.11 - $3.37
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Silo Pharma Inc (5 min.)




Live pricePrice per Share (EOD)
$1.22
Intrinsic Value Per Share
$-12.92 - $-7.90
Total Value Per Share
$-11.41 - $-6.38

2.2. Growth of Silo Pharma Inc (5 min.)




Is Silo Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$6.7m$8.8m-$2.8m-47.0%

How much money is Silo Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$945.8k-$1m$141.1k14.9%
Net Profit Margin-5,247.3%-6,030.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Silo Pharma Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Silo Pharma Inc?

Welcome investor! Silo Pharma Inc's management wants to use your money to grow the business. In return you get a share of Silo Pharma Inc.

First you should know what it really means to hold a share of Silo Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of Silo Pharma Inc is $1.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Silo Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Silo Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.51. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Silo Pharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.21-17.0%-0.21-17.3%-0.21-16.9%-0.12-9.8%-0.08-6.4%
Usd Book Value Change Per Share0.1815.1%-0.04-3.3%-0.24-19.9%0.086.3%0.032.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.1815.1%-0.04-3.3%-0.24-19.9%0.086.3%0.032.2%
Usd Price Per Share1.10-1.37-2.30-1.06-0.58-
Price to Earnings Ratio-1.33--1.67--2.79--1.27--0.56-
Price-to-Total Gains Ratio5.98--0.51--9.46--1.93--1.06-
Price to Book Ratio0.73-1.04-1.14-0.51-0.30-
Price-to-Total Gains Ratio5.98--0.51--9.46--1.93--1.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.22
Number of shares819
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.040.08
Usd Total Gains Per Share-0.040.08
Gains per Quarter (819 shares)-32.6162.86
Gains per Year (819 shares)-130.45251.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-130-1400251241
20-261-2700503492
30-391-4000754743
40-522-53001006994
50-652-660012571245
60-783-790015091496
70-913-920017601747
80-1044-1050020111998
90-1174-1180022632249
100-1305-1310025142500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%6.031.00.016.2%8.043.00.015.7%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%7.013.00.035.0%12.025.00.032.4%18.033.00.035.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%3.00.034.08.1%3.00.048.05.9%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%7.013.00.035.0%12.025.00.032.4%18.033.00.035.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Silo Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.184-0.040+122%-0.243+232%0.077+140%0.026+599%
Book Value Per Share--1.5121.350+12%1.983-24%1.345+12%0.863+75%
Current Ratio--7.9077.881+0%15.927-50%18.364-57%378.508-98%
Debt To Asset Ratio--0.2080.227-8%0.153+36%0.281-26%0.311-33%
Debt To Equity Ratio--0.2630.295-11%0.182+45%0.180+46%0.361-27%
Dividend Per Share----0%-0%-0%0.000-100%
Enterprise Value--3148470.0006300221.239-50%18914249.200-83%9327595.444-66%5182331.754-39%
Eps---0.207-0.211+2%-0.2060%-0.119-42%-0.078-62%
Ev To Ebitda Ratio--infinfnan%-4.896nan%infnan%infnan%
Ev To Sales Ratio--43.66887.378-50%262.325-83%106.250-59%inf+inf%
Free Cash Flow Per Share---0.300-0.213-29%-0.178-41%-0.149-50%-0.092-69%
Free Cash Flow To Equity Per Share--0.088-0.043+149%-0.208+337%0.114-23%0.050+75%
Gross Profit Margin--1.0001.039-4%1.236-19%1.055-5%1.030-3%
Intrinsic Value_10Y_max---7.896--------
Intrinsic Value_10Y_min---12.920--------
Intrinsic Value_1Y_max---0.429--------
Intrinsic Value_1Y_min---0.868--------
Intrinsic Value_3Y_max---1.566--------
Intrinsic Value_3Y_min---2.993--------
Intrinsic Value_5Y_max---3.035--------
Intrinsic Value_5Y_min---5.524--------
Market Cap5471041.200+10%4932906.0006154809.239-20%10291835.700-52%4772676.244+3%2616403.646+89%
Net Profit Margin---51.529-52.473+2%-60.304+17%-91.814+78%-85.967+67%
Operating Margin----0%-60.3150%-76.3780%-4.6190%
Operating Ratio--57.11757.3150%61.315-7%88.849-36%44.309+29%
Pb Ratio0.807+10%0.7271.044-30%1.140-36%0.515+41%0.300+142%
Pe Ratio-1.473-11%-1.328-1.674+26%-2.787+110%-1.275-4%-0.564-58%
Price Per Share1.220+10%1.1001.372-20%2.295-52%1.064+3%0.583+89%
Price To Free Cash Flow Ratio-1.016-11%-0.916-1.708+86%-3.394+271%-1.377+50%-0.806-12%
Price To Total Gains Ratio6.636+10%5.983-0.514+109%-9.460+258%-1.931+132%-1.056+118%
Quick Ratio--3.0196.313-52%23.129-87%18.971-84%370.409-99%
Return On Assets---0.108-0.121+12%-0.102-6%-0.181+67%-0.169+56%
Return On Equity---0.137-0.157+14%-0.120-13%-0.136-1%-0.205+50%
Total Gains Per Share--0.184-0.040+122%-0.243+232%0.077+140%0.026+598%
Usd Book Value--6782263.0006052250.250+12%8894214.500-24%6029711.950+12%3869039.081+75%
Usd Book Value Change Per Share--0.184-0.040+122%-0.243+232%0.077+140%0.026+599%
Usd Book Value Per Share--1.5121.350+12%1.983-24%1.345+12%0.863+75%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Enterprise Value--3148470.0006300221.239-50%18914249.200-83%9327595.444-66%5182331.754-39%
Usd Eps---0.207-0.211+2%-0.2060%-0.119-42%-0.078-62%
Usd Free Cash Flow---1346500.000-956623.500-29%-800118.750-41%-668320.900-50%-411920.892-69%
Usd Free Cash Flow Per Share---0.300-0.213-29%-0.178-41%-0.149-50%-0.092-69%
Usd Free Cash Flow To Equity Per Share--0.088-0.043+149%-0.208+337%0.114-23%0.050+75%
Usd Market Cap5471041.200+10%4932906.0006154809.239-20%10291835.700-52%4772676.244+3%2616403.646+89%
Usd Price Per Share1.220+10%1.1001.372-20%2.295-52%1.064+3%0.583+89%
Usd Profit---928814.000-945859.000+2%-1087016.750+17%-504496.450-46%-334129.811-64%
Usd Revenue--18025.00018025.5000%18025.5000%21553.650-16%13827.865+30%
Usd Total Gains Per Share--0.184-0.040+122%-0.243+232%0.077+140%0.026+598%
 EOD+6 -2MRQTTM+22 -14YOY+12 -245Y+16 -2010Y+22 -16

3.3 Fundamental Score

Let's check the fundamental score of Silo Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.473
Price to Book Ratio (EOD)Between0-10.807
Net Profit Margin (MRQ)Greater than0-51.529
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.019
Current Ratio (MRQ)Greater than17.907
Debt to Asset Ratio (MRQ)Less than10.208
Debt to Equity Ratio (MRQ)Less than10.263
Return on Equity (MRQ)Greater than0.15-0.137
Return on Assets (MRQ)Greater than0.05-0.108
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Silo Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.802
Ma 20Greater thanMa 501.489
Ma 50Greater thanMa 1001.444
Ma 100Greater thanMa 2001.250
OpenGreater thanClose1.350
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Silo Pharma Inc

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore; and has joint development agreement with Kymanox for the design and development of a subcutaneous insertion device for SP-26. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Fundamental data was last updated by Penke on 2025-02-17 00:23:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Silo Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -5,152.9% means that $-51.53 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Silo Pharma Inc:

  • The MRQ is -5,152.9%. The company is making a huge loss. -2
  • The TTM is -5,247.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,152.9%TTM-5,247.3%+94.4%
TTM-5,247.3%YOY-6,030.4%+783.1%
TTM-5,247.3%5Y-9,181.4%+3,934.1%
5Y-9,181.4%10Y-8,596.7%-584.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,152.9%-101.0%-5,051.9%
TTM-5,247.3%-203.6%-5,043.7%
YOY-6,030.4%-199.0%-5,831.4%
5Y-9,181.4%-333.8%-8,847.6%
10Y-8,596.7%-481.5%-8,115.2%
4.3.1.2. Return on Assets

Shows how efficient Silo Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • -10.8% Return on Assets means that Silo Pharma Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Silo Pharma Inc:

  • The MRQ is -10.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.8%TTM-12.1%+1.3%
TTM-12.1%YOY-10.2%-1.9%
TTM-12.1%5Y-18.1%+6.0%
5Y-18.1%10Y-16.9%-1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%-12.4%+1.6%
TTM-12.1%-12.4%+0.3%
YOY-10.2%-11.8%+1.6%
5Y-18.1%-13.2%-4.9%
10Y-16.9%-15.2%-1.7%
4.3.1.3. Return on Equity

Shows how efficient Silo Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • -13.7% Return on Equity means Silo Pharma Inc generated $-0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Silo Pharma Inc:

  • The MRQ is -13.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.7%TTM-15.7%+2.0%
TTM-15.7%YOY-12.0%-3.7%
TTM-15.7%5Y-13.6%-2.1%
5Y-13.6%10Y-20.5%+6.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.7%-15.9%+2.2%
TTM-15.7%-16.6%+0.9%
YOY-12.0%-15.2%+3.2%
5Y-13.6%-19.0%+5.4%
10Y-20.5%-20.5%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Silo Pharma Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Silo Pharma Inc is operating .

  • Measures how much profit Silo Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Silo Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-6,031.5%+6,031.5%
TTM-5Y-7,637.8%+7,637.8%
5Y-7,637.8%10Y-461.9%-7,175.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM--316.3%+316.3%
YOY-6,031.5%-208.2%-5,823.3%
5Y-7,637.8%-367.6%-7,270.2%
10Y-461.9%-483.9%+22.0%
4.3.2.2. Operating Ratio

Measures how efficient Silo Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 57.12 means that the operating costs are $57.12 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Silo Pharma Inc:

  • The MRQ is 57.117. The company is inefficient in keeping operating costs low. -1
  • The TTM is 57.315. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ57.117TTM57.315-0.198
TTM57.315YOY61.315-3.999
TTM57.3155Y88.849-31.534
5Y88.84910Y44.309+44.541
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ57.1172.167+54.950
TTM57.3153.118+54.197
YOY61.3153.194+58.121
5Y88.8494.689+84.160
10Y44.3096.422+37.887
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Silo Pharma Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Silo Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.91 means the company has $7.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Silo Pharma Inc:

  • The MRQ is 7.907. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.881. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.907TTM7.881+0.026
TTM7.881YOY15.927-8.045
TTM7.8815Y18.364-10.483
5Y18.36410Y378.508-360.143
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9073.586+4.321
TTM7.8813.854+4.027
YOY15.9274.496+11.431
5Y18.3645.971+12.393
10Y378.5086.269+372.239
4.4.3.2. Quick Ratio

Measures if Silo Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.02 means the company can pay off $3.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Silo Pharma Inc:

  • The MRQ is 3.019. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.313. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.019TTM6.313-3.294
TTM6.313YOY23.129-16.816
TTM6.3135Y18.971-12.658
5Y18.97110Y370.409-351.438
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0193.068-0.049
TTM6.3133.312+3.001
YOY23.1294.393+18.736
5Y18.9715.972+12.999
10Y370.4096.490+363.919
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Silo Pharma Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Silo Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Silo Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.21 means that Silo Pharma Inc assets are financed with 20.8% credit (debt) and the remaining percentage (100% - 20.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Silo Pharma Inc:

  • The MRQ is 0.208. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.227. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.208TTM0.227-0.019
TTM0.227YOY0.153+0.074
TTM0.2275Y0.281-0.054
5Y0.28110Y0.311-0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2080.340-0.132
TTM0.2270.341-0.114
YOY0.1530.310-0.157
5Y0.2810.363-0.082
10Y0.3110.384-0.073
4.5.4.2. Debt to Equity Ratio

Measures if Silo Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 26.3% means that company has $0.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Silo Pharma Inc:

  • The MRQ is 0.263. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.295. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.263TTM0.295-0.031
TTM0.295YOY0.182+0.113
TTM0.2955Y0.180+0.115
5Y0.18010Y0.361-0.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2630.387-0.124
TTM0.2950.428-0.133
YOY0.1820.391-0.209
5Y0.1800.451-0.271
10Y0.3610.495-0.134
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Silo Pharma Inc generates.

  • Above 15 is considered overpriced but always compare Silo Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -1.33 means the investor is paying $-1.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Silo Pharma Inc:

  • The EOD is -1.473. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.328. Based on the earnings, the company is expensive. -2
  • The TTM is -1.674. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.473MRQ-1.328-0.145
MRQ-1.328TTM-1.674+0.347
TTM-1.674YOY-2.787+1.113
TTM-1.6745Y-1.275-0.400
5Y-1.27510Y-0.564-0.711
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.473-2.221+0.748
MRQ-1.328-2.782+1.454
TTM-1.674-3.254+1.580
YOY-2.787-3.403+0.616
5Y-1.275-6.225+4.950
10Y-0.564-6.819+6.255
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Silo Pharma Inc:

  • The EOD is -1.016. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.916. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.708. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.016MRQ-0.916-0.100
MRQ-0.916TTM-1.708+0.792
TTM-1.708YOY-3.394+1.687
TTM-1.7085Y-1.377-0.331
5Y-1.37710Y-0.806-0.571
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.016-3.007+1.991
MRQ-0.916-3.693+2.777
TTM-1.708-3.891+2.183
YOY-3.394-4.438+1.044
5Y-1.377-8.306+6.929
10Y-0.806-9.274+8.468
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Silo Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.73 means the investor is paying $0.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Silo Pharma Inc:

  • The EOD is 0.807. Based on the equity, the company is cheap. +2
  • The MRQ is 0.727. Based on the equity, the company is cheap. +2
  • The TTM is 1.044. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.807MRQ0.727+0.079
MRQ0.727TTM1.044-0.317
TTM1.044YOY1.140-0.096
TTM1.0445Y0.515+0.530
5Y0.51510Y0.300+0.215
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8071.910-1.103
MRQ0.7272.190-1.463
TTM1.0442.397-1.353
YOY1.1402.465-1.325
5Y0.5153.815-3.300
10Y0.3004.512-4.212
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Silo Pharma Inc.

4.8.1. Institutions holding Silo Pharma Inc

Institutions are holding 4.093% of the shares of Silo Pharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Financial Advocates Investment Management2.17630.00596280755009.5974
2023-12-31UBS Group AG1.138032843328430
2023-12-31Vanguard Group Inc0.566016334183012.6172
2023-12-31Geode Capital Management, LLC0.560601617900
2023-12-31TWO SIGMA SECURITIES, LLC0.44310.000212788127880
2023-12-31State Street Corporation0.433101250000
2023-12-31Tower Research Capital LLC0.24280.00017007211743.2924
2023-12-31Westside Investment Management, Inc.0.003309400
2023-12-31FWL INVESTMENT MANAGEMENT, LLC0.00280.00018000
2023-12-31Wells Fargo & Co0.000702015.2632
2023-09-30JPMorgan Chase & Co000-200-100
Total 5.56670.0063160652+54879+34.2%

4.9.2. Funds holding Silo Pharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.574401633400
2024-02-29Fidelity Extended Market Index0.53140.000115110-73-0.4808
2024-03-31NT Ext Equity Mkt Idx Fd - L0.12250.0001348300
2023-12-31Northern Trust Extended Eq Market Idx0.12250.0001348300
2024-02-29Fidelity Series Total Market Index0.035099600
2024-02-29Spartan Extended Market Index Pool E0.0026073730
Total 1.38840.00033947900.0%

5.3. Insider Transactions

Insiders are holding 4.302% of the shares of Silo Pharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-04Eric WeisblumBUY6001.96
2024-04-01Eric WeisblumBUY11001.91
2024-03-28Eric WeisblumBUY34081.94
2023-12-19Eric WeisblumBUY5001.63
2023-12-14Eric WeisblumBUY2001.5
2023-12-07Eric WeisblumBUY3241.36
2023-12-05Eric WeisblumBUY6001.39
2023-11-30Eric WeisblumBUY10001.53
2023-11-27Eric WeisblumBUY2501.78
2023-11-22Eric WeisblumBUY4001.68
2023-11-16Eric WeisblumBUY11001.33
2023-05-26Daniel E RyweckBUY10002.13
2023-05-17Eric WeisblumBUY25002.06
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets8,567
Total Liabilities1,784
Total Stockholder Equity6,782
 As reported
Total Liabilities 1,784
Total Stockholder Equity+ 6,782
Total Assets = 8,567

Assets

Total Assets8,567
Total Current Assets8,262
Long-term Assets305
Total Current Assets
Cash And Cash Equivalents 4,861
Short-term Investments 3,154
Other Current Assets 246
Total Current Assets  (as reported)8,262
Total Current Assets  (calculated)8,262
+/-0
Long-term Assets
Intangible Assets 244
Long-term Assets Other 61
Long-term Assets  (as reported)305
Long-term Assets  (calculated)305
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,045
Long-term Liabilities740
Total Stockholder Equity6,782
Total Current Liabilities
Total Current Liabilities  (as reported)1,045
Total Current Liabilities  (calculated)0
+/- 1,045
Long-term Liabilities
Long-term Liabilities  (as reported)740
Long-term Liabilities  (calculated)0
+/- 740
Total Stockholder Equity
Total Stockholder Equity (as reported)6,782
Total Stockholder Equity (calculated)0
+/- 6,782
Other
Capital Stock0
Common Stock Shares Outstanding 4,484
Net Invested Capital 6,782
Net Working Capital 7,217



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-31
> Total Assets 
0
26
5
2
4
1
0
0
10
369
1,259
2,207
2,933
2,494
2,822
2,772
2,836
2,864
2,416
2,450
2,293
1,439
1,300
2,082
1,936
1,427
1,641
1,350
1,435
855
536
387
494
404
2,796
2,204
1,427
5,501
5,004
11,390
10,490
9,716
9,045
13,049
11,643
11,024
10,246
8,987
7,746
6,941
8,038
8,567
8,5678,0386,9417,7468,98710,24611,02411,64313,0499,0459,71610,49011,3905,0045,5011,4272,2042,7964044943875368551,4351,3501,6411,4271,9362,0821,3001,4392,2932,4502,4162,8642,8362,7722,8222,4942,9332,2071,25936910001425260
   > Total Current Assets 
0
26
5
2
4
1
0
0
10
369
1,259
2,011
1,921
1,698
2,046
1,763
1,278
1,075
815
759
571
595
665
565
431
363
1,641
776
1,053
626
306
157
494
404
2,796
2,087
1,427
5,482
4,974
11,302
10,402
9,618
8,947
12,912
11,572
10,955
10,178
8,921
7,681
6,878
7,729
8,262
8,2627,7296,8787,6818,92110,17810,95511,57212,9128,9479,61810,40211,3024,9745,4821,4272,0872,7964044941573066261,0537761,6413634315656655955717598151,0751,2781,7632,0461,6981,9212,0111,25936910001425260
       Cash And Cash Equivalents 
0
26
5
2
4
1
0
0
10
369
1,259
2,011
1,917
1,548
2,004
1,740
1,263
1,036
779
723
532
543
579
495
366
302
295
776
626
337
77
25
112
9
1,919
1,646
1,128
4,637
4,151
10,261
9,837
9,068
8,734
12,253
11,367
4,666
159
200
3,524
2,668
4,506
4,861
4,8614,5062,6683,5242001594,66611,36712,2538,7349,0689,83710,2614,1514,6371,1281,6461,919911225773376267762953023664955795435327237791,0361,2631,7402,0041,5481,9172,0111,25936910001425260
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,320
0
404
228
163
9
9
9
9
9
0
570
600
820
420
344
113
78
3
6,017
9,829
8,571
4,141
4,076
3,102
3,154
3,1543,1024,0764,1418,5719,8296,01737811334442082060057009999916322840401,32000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
1
4
0
5
5
6
9
16
16
28
50
59
43
50
56
0
0
0
0
200
200
200
200
187
90
24
0
0
60
61
62
64
1
66
67
68
70
0
0
0
0
00007068676616462616000249018720020020020000005650435950281616965504100000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
150
38
19
9
30
20
20
10
2
27
27
16
5
1,347
0
22
34
39
24
16
29
525
311
241
230
168
221
145
206
100
581
136
204
121
80
16
134
120
246
246120134168012120413658110020614522116823024131152529162439342201,3475162727210202030919381500000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
196
1,012
795
776
1,008
1,558
1,789
1,602
1,692
1,722
844
635
1,517
1,505
1,064
1,320
574
383
229
229
229
0
0
0
117
0
19
30
88
88
98
97
137
71
69
68
66
65
64
309
305
30530964656668697113797988888301901170002292292293835741,3201,0641,5051,5176358441,7221,6921,6021,7891,5581,0087767951,01219600000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001480000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135
29
29
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
247
244
2442470000000000000000002929291350000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,320
0
0
0
0
200
0
0
0
117
0
19
30
88
88
98
97
137
0
0
68
0
0
0
0
0
00000680013797988888301901170002000000-1,32000000000000000000000000000
> Total Liabilities 
0
4
-5
4
19
21
29
41
54
35
715
419
412
403
406
403
401
400
401
491
437
449
453
490
421
430
438
445
429
448
433
488
517
666
492
134
146
1,273
1,238
1,239
1,428
1,213
1,171
1,196
1,302
1,580
1,950
1,490
1,569
1,649
2,081
1,784
1,7842,0811,6491,5691,4901,9501,5801,3021,1961,1711,2131,4281,2391,2381,2731461344926665174884334484294454384304214904534494374914014004014034064034124197153554412921194-540
   > Total Current Liabilities 
0
4
0
4
4
6
14
26
54
35
715
17
12
3
6
3
1
0
1
91
37
49
53
90
21
30
38
45
29
48
33
88
117
266
80
122
142
327
264
283
490
293
269
312
436
732
1,120
679
776
874
1,323
1,045
1,0451,3238747766791,1207324363122692934902832643271421228026611788334829453830219053493791101363121771535542614644040
       Short-term Debt 
0
0
0
0
0
0
0
5
20
20
20
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
5
25
62
159
7
7
15
18
192
211
0
0
0
0
0
660
1,048
607
0
0
0
0
00006071,048660000002111921815771596225522000000000000000001520202050000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25
62
159
7
7
15
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000018157715962250000000000000000000000000000000
       Accounts payable 
0
4
0
4
4
6
14
0
34
15
12
4
12
0
0
0
0
0
0
0
73
49
53
90
21
30
38
45
29
0
0
62
55
106
73
115
127
238
192
211
418
156
156
224
364
660
1,048
607
703
0
0
0
0007036071,048660364224156156418211192238127115731065562002945383021905349730000000124121534014644040
       Other Current Liabilities 
0
0
0
0
0
0
0
21
0
0
684
-2
0
3
6
3
1
0
1
91
37
0
0
0
0
0
0
0
0
26
28
0
0
0
80
122
0
2
192
211
418
65
41
16
1
660
1,048
607
0
0
0
0
00006071,0486601164165418211192201228000028260000000037911013630-268400210000000
   > Long-term Liabilities 
0
4
0
4
15
15
15
16
54
35
32
402
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
400
412
12
4
946
974
956
938
920
902
884
866
848
830
812
794
776
758
740
740758776794812830848866884902920938956974946412412400400400400400400400400400400400400400400400400400400400400400400402323554161515154040
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
945
974
956
938
920
902
884
0
0
830
0
0
0
0
0
00000830008849029209389569749450000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
16
14
13
62
61
0
58
0
0
0
0
0
00000580616213141617000000000000000000000000000000000000000
> Total Stockholder Equity
0
22
5
-2
-15
-20
-29
-41
-44
333
544
1,789
2,521
2,091
2,416
2,369
2,435
2,464
2,015
1,959
1,855
990
847
1,591
1,515
996
1,203
905
1,007
407
103
-101
-23
-262
2,304
2,071
1,281
4,228
3,766
10,151
9,062
8,503
7,874
11,853
10,341
9,444
8,296
7,497
6,177
5,292
5,958
6,782
6,7825,9585,2926,1777,4978,2969,44410,34111,8537,8748,5039,06210,1513,7664,2281,2812,0712,304-262-23-1011034071,0079051,2039961,5151,5918479901,8551,9592,0152,4642,4352,3692,4162,0912,5211,789544333-44-41-29-20-15-25220
   Common Stock
0
3
3
3
3
3
3
3
3
3
4
4
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
2
2
2
2
2
8
9
9
9
10
10
10
10
10
0
0
0
0
0
0
0
0
0
000000000101010101099982222255555555555555555443333333330
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
33
469
38
-297
0
-126
-110
-571
-364
-334
-521
-566
-692
-775
-947
-1,122
-971
0
-400
-400
-400
0
-400
-400
0
0
0
0
0
0
0
0
0
0
5
-3
-1
-6
0
0
0
000-6-1-350000000000-400-4000-400-400-4000-971-1,122-947-775-692-566-521-334-364-571-110-1260-297384693300000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
1,123
1,123
1,123
1,123
1,123
1,123
1,123
1,143
1,543
1,759
2,591
2,918
2,947
3,753
3,532
3,786
3,870
3,517
2,319
1,893
1,433
1,408
2,017
2,094
1,839
2,790
2,152
2,171
2,048
2,109
2,170
2,631
2,631
6,635
7,035
7,035
12,316
12,315
12,315
12,315
12,360
12,389
17,361
17,512
17,516
17,389
17,248
17,055
0
0
0
00017,05517,24817,38917,51617,51217,36112,38912,36012,31512,31512,31512,3167,0357,0356,6352,6312,6312,1702,1092,0482,1712,1522,7901,8392,0942,0171,4081,4331,8932,3193,5173,8703,7863,5323,7532,9472,9182,5911,7591,5431,1431,1231,1231,1231,1231,1231,1231,1230



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue72
Cost of Revenue-877
Gross Profit-805-805
 
Operating Income (+$)
Gross Profit-805
Operating Expense-3,050
Operating Income-3,856-3,856
 
Operating Expense (+$)
Research Development845
Selling General Administrative3,077
Selling And Marketing Expenses1,336
Operating Expense3,0505,258
 
Net Interest Income (+$)
Interest Income361
Interest Expense-5
Other Finance Cost-2
Net Interest Income354
 
Pretax Income (+$)
Operating Income-3,856
Net Interest Income354
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,631-4,080
EBIT - interestExpense = -5
-3,631
-3,696
Interest Expense5
Earnings Before Interest and Taxes (EBIT)0-3,626
Earnings Before Interest and Taxes (EBITDA)-3,856
 
After tax Income (+$)
Income Before Tax-3,631
Tax Provision-0
Net Income From Continuing Ops-4,242-3,631
Net Income-3,701
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,928
Total Other Income/Expenses Net225-354
 

Technical Analysis of Silo Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Silo Pharma Inc. The general trend of Silo Pharma Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Silo Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Silo Pharma Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.5 < 2.09 < 3.37.

The bearish price targets are: 1.35 > 1.2 > 1.11.

Tweet this
Silo Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Silo Pharma Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Silo Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Silo Pharma Inc. The current macd is -0.06597515.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Silo Pharma Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Silo Pharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Silo Pharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Silo Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartSilo Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Silo Pharma Inc. The current adx is 19.34.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Silo Pharma Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Silo Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Silo Pharma Inc. The current sar is 1.47240052.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Silo Pharma Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Silo Pharma Inc. The current rsi is 35.80. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Silo Pharma Inc Daily Relative Strength Index (RSI) ChartSilo Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Silo Pharma Inc. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Silo Pharma Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Silo Pharma Inc Daily Stochastic Oscillator ChartSilo Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Silo Pharma Inc. The current cci is -135.24737646.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Silo Pharma Inc Daily Commodity Channel Index (CCI) ChartSilo Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Silo Pharma Inc. The current cmo is -42.27386102.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Silo Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartSilo Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Silo Pharma Inc. The current willr is -94.73684211.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Silo Pharma Inc Daily Williams %R ChartSilo Pharma Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Silo Pharma Inc.

Silo Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Silo Pharma Inc. The current atr is 0.15568373.

Silo Pharma Inc Daily Average True Range (ATR) ChartSilo Pharma Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Silo Pharma Inc. The current obv is 437,986,476.

Silo Pharma Inc Daily On-Balance Volume (OBV) ChartSilo Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Silo Pharma Inc. The current mfi is 25.68.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Silo Pharma Inc Daily Money Flow Index (MFI) ChartSilo Pharma Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Silo Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Silo Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Silo Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.802
Ma 20Greater thanMa 501.489
Ma 50Greater thanMa 1001.444
Ma 100Greater thanMa 2001.250
OpenGreater thanClose1.350
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Silo Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on Silo Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Silo Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Silo Pharma Inc

I send you an email if I find something interesting about Silo Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Silo Pharma Inc.

Receive notifications about Silo Pharma Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.